1,463
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Prevalence of alcohol and drugs among drivers killed in road traffic crashes in Norway during 2011–2020

ORCID Icon &
Pages 256-261 | Received 01 Nov 2022, Accepted 26 Jan 2023, Published online: 10 Feb 2023

Figures & data

Table 1. Prevalence (numbers in brackets) of alcohol and drug groups in concentrations at or above the legal limits for drivers killed in road traffic crashes in Norway during 2011–2020.

Figure 1. Annual numbers of motor vehicle drivers killed in road traffic crashes and numbers analyzed for alcohol and drugs in blood with regression lines.

Figure 1. Annual numbers of motor vehicle drivers killed in road traffic crashes and numbers analyzed for alcohol and drugs in blood with regression lines.

Table 2. Prevalence (numbers in brackets) of alcohol and drug concentrations indicating impairment and witness reports indicating impairment for non-tested drivers.

Figure 2. Proportion (%) of drivers killed in road traffic crashes (n = 645) who tested positive for alcohol, illicit drugs, medicinal drugs, and any substance, across age groups, and sexes.

Figure 2. Proportion (%) of drivers killed in road traffic crashes (n = 645) who tested positive for alcohol, illicit drugs, medicinal drugs, and any substance, across age groups, and sexes.

Figure 3. Proportion (%) of drivers killed in road traffic crashes (n = 645) who tested positive for alcohol, illicit drugs, medicinal drugs, and any substance, across time intervals. WD = weekdays; WE = weekends.

Figure 3. Proportion (%) of drivers killed in road traffic crashes (n = 645) who tested positive for alcohol, illicit drugs, medicinal drugs, and any substance, across time intervals. WD = weekdays; WE = weekends.

Table 3. Prevalence (numbers in brackets) of alcohol and drug groups in concentrations at or above the legal limits in blood samples from the car and van drivers and motorcycle and moped riders killed in road traffic crashes, in total, for the periods 2001–2010 and 2011–2020.

Supplemental material

Supplemental Material

Download Zip (19.6 KB)

Data availability statement

We do not have permission to share research data.